'A Good Year' with John LaMattina

Guest:

John LaMattina, Senior Partner, Pure Tech Ventures
Bio and Contact Info

Listen (6:27) Comparing drug approvals: 2014 with 1996

Listen (7:10) More rational drug development?

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe